scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-0404.1991.TB03962.X |
P698 | PubMed publication ID | 1887756 |
P2093 | author name string | K Abe | |
Y Nishikawa | |||
M Kameyama | |||
H Fujimura | |||
S Yorifuji | |||
N Hirono | |||
N Nishitani | |||
T Mezaki | |||
P433 | issue | 6 | |
P921 | main subject | lactic acidosis | Q1500373 |
mitochondrial myopathy | Q6881881 | ||
P304 | page(s) | 356-359 | |
P577 | publication date | 1991-06-01 | |
P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
P1476 | title | Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) | |
P478 | volume | 83 |
Q42928969 | Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport |
Q36225925 | Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects |
Q38114007 | Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications |
Q28375775 | Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats |
Q73614293 | Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases |
Q74579034 | Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry |
Q48173034 | Evidence of altered energy metabolism in autistic children |
Q41272025 | Mitochondrial encephalopathies |
Q91728645 | Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction |
Q34218646 | Nutritional cofactor treatment in mitochondrial disorders |
Q43585280 | Subcutaneous microdialysis in mitochondrial cytopathy |
Q36492305 | The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options |
Q41180888 | The treatment of congenital lactic acidoses |
Q57086168 | The use of lymphocytes to screen for oxidative phosphorylation disorders |
Q45305438 | Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. |
Q35718544 | Therapeutic effects of coenzyme Q10 in neurodegenerative diseases |
Q24200432 | Treatment for mitochondrial disorders |
Q24244543 | Treatment for mitochondrial disorders |
Q40898218 | Treatment of mitochondrial disease |
Q80348054 | [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?] |
Search more.